APYX
Price
$1.99
Change
-$0.03 (-1.49%)
Updated
Aug 29 closing price
Capitalization
75.26M
67 days until earnings call
INFU
Price
$10.78
Change
+$0.05 (+0.47%)
Updated
Aug 29 closing price
Capitalization
220.19M
72 days until earnings call
Interact to see
Advertisement

APYX vs INFU

Header iconAPYX vs INFU Comparison
Open Charts APYX vs INFUBanner chart's image
Apyx Medical
Price$1.99
Change-$0.03 (-1.49%)
Volume$17.89K
Capitalization75.26M
InfuSystem Holdings
Price$10.78
Change+$0.05 (+0.47%)
Volume$314.25K
Capitalization220.19M
APYX vs INFU Comparison Chart in %
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INFU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. INFU commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and INFU is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (APYX: $1.99 vs. INFU: $10.78)
Brand notoriety: APYX and INFU are both not notable
APYX represents the Medical/Nursing Services, while INFU is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: APYX: 18% vs. INFU: 111%
Market capitalization -- APYX: $75.26M vs. INFU: $220.19M
APYX [@Medical/Nursing Services] is valued at $75.26M. INFU’s [@Pharmaceuticals: Other] market capitalization is $220.19M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileINFU’s FA Score has 0 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • INFU’s FA Score: 0 green, 5 red.
According to our system of comparison, APYX is a better buy in the long-term than INFU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 1 TA indicator(s) are bullish while INFU’s TA Score has 7 bullish TA indicator(s).

  • APYX’s TA Score: 1 bullish, 8 bearish.
  • INFU’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, INFU is a better buy in the short-term than APYX.

Price Growth

APYX (@Medical/Nursing Services) experienced а -4.78% price change this week, while INFU (@Pharmaceuticals: Other) price change was +12.64% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.77%. For the same industry, the average monthly price growth was +6.45%, and the average quarterly price growth was +9.91%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.93%. For the same industry, the average monthly price growth was +6.00%, and the average quarterly price growth was +26.47%.

Reported Earning Dates

APYX is expected to report earnings on Nov 06, 2025.

INFU is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.77% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.93% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INFU($220M) has a higher market cap than APYX($75.3M). INFU YTD gains are higher at: 27.574 vs. APYX (25.949). INFU has higher annual earnings (EBITDA): 23.5M vs. APYX (-10.64M). APYX has more cash in the bank: 29.3M vs. INFU (720K). INFU has less debt than APYX: INFU (30.5M) vs APYX (39.1M). INFU has higher revenues than APYX: INFU (140M) vs APYX (46.5M).
APYXINFUAPYX / INFU
Capitalization75.3M220M34%
EBITDA-10.64M23.5M-45%
Gain YTD25.94927.57494%
P/E RatioN/A44.92-
Revenue46.5M140M33%
Total Cash29.3M720K4,069%
Total Debt39.1M30.5M128%
FUNDAMENTALS RATINGS
APYX vs INFU: Fundamental Ratings
APYX
INFU
OUTLOOK RATING
1..100
3044
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9972
PRICE GROWTH RATING
1..100
4235
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APYX's Valuation (54) in the Medical Specialties industry is in the same range as INFU (72). This means that APYX’s stock grew similarly to INFU’s over the last 12 months.

APYX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as INFU (100). This means that APYX’s stock grew similarly to INFU’s over the last 12 months.

INFU's SMR Rating (72) in the Medical Specialties industry is in the same range as APYX (99). This means that INFU’s stock grew similarly to APYX’s over the last 12 months.

INFU's Price Growth Rating (35) in the Medical Specialties industry is in the same range as APYX (42). This means that INFU’s stock grew similarly to APYX’s over the last 12 months.

INFU's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as APYX (100). This means that INFU’s stock grew similarly to APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXINFU
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 6 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INFU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UURAF2.930.01
+0.41%
Ucore Rare Metals, Inc.
IPGDF3.60N/A
N/A
IGO Ltd
GTIC0.08N/A
N/A
GreenTech Innovations, Inc.
AKZOY23.13-0.01
-0.02%
Akzo Nobel N.V.
NSRPF0.07-0.01
-7.61%
Novo Resources Corp

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-1.49%
CORBF - APYX
36%
Loosely correlated
N/A
CLPT - APYX
26%
Poorly correlated
N/A
INGN - APYX
26%
Poorly correlated
+0.38%
EMBC - APYX
25%
Poorly correlated
+0.91%
INFU - APYX
25%
Poorly correlated
+0.47%
More